Literature DB >> 26547032

An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.

Rita Török1, Dénes Zádori1, Nóra Török1, Éva Csility1, László Vécsei2, Péter Klivényi3.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder, with cases of either familial or sporadic origin. Several polymorphisms in a number of genes have been proved to have an important role in the development of PD. Particular attention has recently been paid to genes of the glucocerebrosidase (GBA) and the vacuolar protein sorting-associated protein 35 (VPS35). In this study, the three most common mutations (L444P, N370S and R120W) of the GBA gene and the D620N mutation of the VPS35 gene were examined in 124 Hungarian patients diagnosed with sporadic PD (SPD) and 122 control subjects. The frequency of the L444P mutation of the GBA gene proved to be higher in the PD patients (2.4%) than in the controls (0%), although the difference was not statistically significant. All the patients who carried the mutant allele were in the early-onset PD (EOPD) group. However, neither the R120W nor the N370S variant of the GBA gene nor D620N mutation of the VPS35 gene were detected among the PD cases or the controls. Even though these results suggest that the studied mutations are quite rare in SPD patients, the most frequent L444P mutation of the GBA gene may be associated with the development of EOPD in the Hungarian population.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  GBA mutations; L444P; Parkinson’s disease; VPS35 mutation

Mesh:

Substances:

Year:  2015        PMID: 26547032     DOI: 10.1016/j.neulet.2015.11.001

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease.

Authors:  Rita Maszlag-Török; Fanni A Boros; László Vécsei; Péter Klivényi
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

2.  The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson's Disease in the Hungarian Population.

Authors:  Sándor Márki; Anikó Göblös; Eszter Szlávicz; Nóra Török; Péter Balicza; Benjamin Bereznai; Annamária Takáts; József Engelhardt; Péter Klivényi; László Vécsei; Mária Judit Molnár; Nikoletta Nagy; Márta Széll
Journal:  Parkinsons Dis       Date:  2018-04-03

3.  Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Yuan Zhang; Li Shu; Qiying Sun; Xun Zhou; Hongxu Pan; Jifeng Guo; Beisha Tang
Journal:  Front Mol Neurosci       Date:  2018-02-15       Impact factor: 5.639

4.  Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease.

Authors:  Jodi Maple-Grødem; Ingvild Dalen; Ole-Bjørn Tysnes; Angus D Macleod; Lars Forsgren; Carl E Counsell; Guido Alves
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

Review 5.  Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review.

Authors:  Ying-Fa Chen; Yung-Yee Chang; Min-Yu Lan; Pei-Lung Chen; Chin-Hsien Lin
Journal:  BMC Neurol       Date:  2017-10-06       Impact factor: 2.474

Review 6.  A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson's Disease.

Authors:  Yuan Zhang; Li Shu; Xun Zhou; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Parkinsons Dis       Date:  2018-09-27

7.  Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts.

Authors:  Jodi Maple-Grødem; Kimberly C Paul; Ingvild Dalen; Kathie J Ngo; Darice Wong; Angus D Macleod; Carl E Counsell; David Bäckström; Lars Forsgren; Ole-Bjørn Tysnes; Cynthia D J Kusters; Brent L Fogel; Jeff M Bronstein; Beate Ritz; Guido Alves
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.